Cn110693860a ketoprofen jiudian?

What is Cn110693860a Ketoprofen Jiudian?

Cn110693860a ketoprofen jiudian is a Chinese patent application for a novel formulation of ketoprofen, a nonsteroidal anti-inflammatory drug (NSAID).

What is Ketoprofen Used For?

[1] Ketoprofen is primarily used to treat pain, inflammation, and fever. It is often prescribed for conditions such as arthritis, sprains, strains, and menstrual cramps.

Why is This Patent Novel?

This patent application describes a novel crystalline form of ketoprofen, which may offer improved stability, solubility, and bioavailability compared to existing formulations. The patent's novelty lies in the specific crystal structure and process for producing this crystalline form.

What is the Difference Between Cn110693860a and Existing Ketoprofen Formulations?

While the patent does not explicitly compare Cn110693860a to existing formulations, the novel crystalline form may provide enhanced therapeutic benefits, such as faster onset of action or improved patient compliance, compared to traditional ketoprofen formulations.

Who is Responsible for Filing This Patent?

The patent application was filed under the name jiudian, which is likely the name of the company or research institution responsible for developing this novel formulation of ketoprofen.

When Can We Expect This Patent to Expire?

The patent application does not provide information on the expected expiration date or the current status of the patent. However, we can assume that the patent will expire when it reaches the end of its term, typically 20 years from the date of filing, unless it is extended or invalidated by subsequent court decisions.

What Are Potential Risks or Side Effects of Cn110693860a Ketoprofen Jiudian?

As with any medication, Cn110693860a ketoprofen jiudian may carry potential risks or side effects, such as gastrointestinal upset, kidney damage, or allergic reactions. However, without further information on the specific formulation, it is difficult to determine the exact risks associated with this novel ketoprofen formulation.

Citations:
1 US Patent 6046157 B1 - Ketoprofen formulation.

Sources:
1. Cn110693860a patent application.
2. DrugPatentWatch.com.